• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Trulicity

Mounjaro tirzepatide
Pharma

Lilly's Mounjaro scores in Type 2 diabetes trial in kids 10-17

A phase 3 trial of Eli Lilly's Mounjaro in kids ages 10-17 with Type 2 diabetes has demonstrated the drug's effectiveness in controlling blood sugar.
Kevin Dunleavy Sep 18, 2025 11:22am
Mounjaro tirzepatide

Mounjaro measures up to Trulicity in Eli Lilly cardio trial

Jul 31, 2025 8:12am
FDA

Lilly's Branchburg production site in trouble with the FDA again

Jan 22, 2024 11:35am
Eli Lilly

Lilly moves to settle whistleblower lawsuit

Sep 29, 2023 11:35am
Eli Lilly

Lilly's obesity drug tirzepatide may be a lifetime drug for some

Apr 27, 2023 3:39pm
Inflation Reduction Act

Moody's identifies drugs destined for CMS price negotiations

Mar 30, 2023 9:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings